Xavier Jacq in

Xavier Jacq

Login to view DISC.
Chief Scientific Officer at MitoRx Therapeutics
📍 Greater Cambridge Area, United Kingdom

Xavier Jacq is the Chief Scientific Officer at MitoRx Therapeutics, leveraging extensive expertise in drug discovery, biochemistry, and molecular biology. His distinguished background includes a Ph. D. from Université Louis Pasteur, postdoctoral research at Columbia University, and multiple scientific leadership and advisory roles across the industry.

He is keenly interested in developing novel therapeutics for metabolic diseases, particularly obesity, and frequently presents new findings at major international conferences. His work also extends to AI applications in the pharmaceutical industry through his board-level involvement.

He is a co-inventor on multiple patents for novel inhibitors of cysteine proteases, designed specifically for therapeutic applications in oncology.

Read the full overview →
Experience
32 Years
Current Role
Chief Scientific Officer
Job Level
Leadership
Location
Greater Cambridge Area, United Kingdom
Personality Overview

How Xavier shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Xavier cares about

Obesity Treatments
He recently presented his company's latest discoveries in obesity models at major conferences like EASD and ADA, showing a strong current focus on this therapeutic area.
Enzyme Inhibition
His publications and patents detail his work on deubiquitylating enzymes (DUBs) and the development of novel inhibitors for cysteine proteases for therapeutic use.
+5 more topics Login to view topics
Career

Work history

5-2025
Chief Scientific Officer
MitoRx Therapeutics
5-2024
Board Member-Non Executive Director
Evariste
1-2023 - 5-2025
Scientific Advisory Board Member
Ubiquigent Ltd
12-2022 - 5-2025
Chief Scientific Officer
MoA Technology
1-2022 - 12-2022
Senior Vice President
Dunad Therapeutics
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1997 - 2000
PostDoc
Columbia University
1993 - 1997
PhD
Université Louis Pasteur (Strasbourg I)
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Xavier. Free, 10 seconds.